- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 16.06. | Exousia Bio, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 09.06. | Exousia Pro, Inc.: NexTel Medical Corp. Announces Groundbreaking, First-of-Its-Kind Exosome Characterization Study with Penn State University | 731 | GlobeNewswire (Europe) | Led by Scientific Advisory Board Members Dr. John Bitzer and Dr. Marvin Hausman, the Study Utilizes Advanced Mass Spectrometry to Identify the Precise Bioactive Healing Compounds Within Proprietary... ► Artikel lesen | |
| 02.06. | Exousia Pro, Inc.: NexTel Medical Corp. Executes Definitive Purchase Agreements to Acquire JumpstartRx and NueVistraMed, Expanding Telehealth Footprint and Accelerating Maxasome Commercialization | 258 | GlobeNewswire (Europe) | Acquisitions bring immediate $135,000 in monthly recurring revenue prior to near-term scaling initiatives; Transaction structured as non-dilutive to $MAJI shareholders. ORLANDO, Fla., June 02, 2026... ► Artikel lesen | |
| 11.05. | Exousia Pro, Inc.: NexTel Medical Corp Enters Final Stage for Commercial Launch; Sets Sights on Revenue Generation and OTCQB Uplist | 243 | GlobeNewswire (Europe) | ORLANDO, Fla., May 11, 2026 (GLOBE NEWSWIRE) -- NexTel Medical Corp (f/k/a Exousia Pro, Inc.) (OTCPK: MAJI), a clinical-stage biotechnology leader specializing in proprietary exosome-based delivery... ► Artikel lesen | |
| 14.04. | Exousia Bio, Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | - | SEC Filings | ||
| EXOUSIA Aktie jetzt für 0€ handeln | |||||
| 07.04. | Exousia Pro, Inc.: NexTel Medical Corp Announces Pivotal Milestone in Commercial Launch of Patent-Protected NANOG DNA Cancer Screening Test | 1 | GlobeNewswire (USA) | ||
| 17.03. | Exousia Bio, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 16.03. | Exousia Pro, Inc. Announces Favorable Litigation Settlement, Highlighting Significant Debt Elimination and Share Cancellation to Enhance Shareholder Value | 516 | GlobeNewswire (Europe) | ORLANDO, Fla., March 16, 2026 (GLOBE NEWSWIRE) -- Exousia Pro, Inc. (OTCPK: MAJI), a clinical-stage biotechnology leader specializing in proprietary exosome-based delivery systems, today announced... ► Artikel lesen | |
| 05.03. | Exousia Pro, Inc. Announces Strategic Elimination of Future Dilutive Issuance of 47 Million Shares, Progresses Toward Definitive Agreements for Telehealth Acquisitions | 144 | GlobeNewswire (Europe) | ORLANDO, Fla., March 05, 2026 (GLOBE NEWSWIRE) -- Exousia Pro, Inc. (OTCPK: MAJI), a clinical-stage biotechnology leader specializing in proprietary exosome-based delivery systems, is pleased to announce... ► Artikel lesen | |
| 10.02. | Exousia Pro, Inc. Accelerates Strategic Expansion with Third Telehealth Acquisition; Strengthens Pathway to Low-Cost Customer Acquisition | 1 | GlobeNewswire (USA) | ||
| 11.12.25 | Exousia Pro, Inc. Announces Executed LOI for Strategic Acquisition of High-Revenue Telehealth Platform to Accelerate Nutraceutical Commercialization | 488 | ACCESS Newswire | ORLANDO, FL / ACCESS Newswire / December 11, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on proprietary exosome-based delivery systems, is excited to announce... ► Artikel lesen | |
| 05.12.25 | Exousia Pro, Inc. Revolutionizes Nutraceuticals With Launch Of Maxasome: The First All-Natural, Biologically Active Exosomal Supplement | 439 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / December 5, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company leveraging proprietary exosome-based delivery systems, today announced... ► Artikel lesen | |
| 02.12.25 | Exousia Pro, Inc. Completes Exclusive Licensing Agreement With the University of Central Florida for Novel Cancer Diagnostic and Therapy Platforms | 507 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / December 2, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on advanced exosome-based delivery systems, today announced the... ► Artikel lesen | |
| 02.12.25 | Exousia Bio, Inc.: LAMY Completes Strategic Acquisition of Cancer Therapy Innovator Exousia AI, Inc. | 375 | GlobeNewswire (Europe) | EXOUSIA AI SECURES HIGH-VALUE ORPHAN DRUG DESIGNATION ORLANDO, Fla., Dec. 02, 2025 (GLOBE NEWSWIRE) -- LAMY, to become Exousia Bio, Inc. (OTCPINK: LMMY) (the "Company" or "Exo Bio"), operating as... ► Artikel lesen | |
| 17.11.25 | Exousia Pro, Inc.: Exousia Pro Initiates Strategic Realignment, Acquires Controlling Stake in SEC-Reporter Lamy in All-stock Exchange Transaction for Exousia AI, to Advance Growth and Enhance Shareholder Value | 525 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / November 17, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on advanced exosome-based delivery systems, today announced it... ► Artikel lesen | |
| 04.11.25 | Exousia Pro, Inc.: Exousia Pro Announces Breakthrough In Exosome-Based Delivery | 669 | ACCESS Newswire | Successful loading of CBD material accelerates the path to revenue. ORLANDO, FL / ACCESS Newswire / November 4, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company focused... ► Artikel lesen | |
| 28.10.25 | Exousia Pro, Inc.: Exousia Pro is Excited to Announce that it has Received Orphan Drug Designation from the FDA | 492 | ACCESS Newswire | Exousia Pro is in a unique position, as only 11% of ODAs are awarded at the preclinical stage. ORLANDO, FLORIDA / ACCESS Newswire / October 28, 2025 / Exousia Pro, Inc. (formerly Marijuana, Inc.) (OTCPINK:MAJI)... ► Artikel lesen | |
| 29.09.25 | Exousia Pro, Inc.: Exousia Pro Announces Groundbreaking Study to Revolutionize the Global Edibles Market with CBD-Loaded Exosomes | 535 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / September 29, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company focused on advanced exosome-based therapies, today announced its plan... ► Artikel lesen | |
| 26.09.25 | Exousia Pro, Inc.: Exousia Pro Reports Positive Outcome in Legal Proceeding | 518 | ACCESS Newswire | Focused on Protecting Shareholder Value and Advancing Core Business ORLANDO, FLORIDA / ACCESS Newswire / September 26, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company... ► Artikel lesen | |
| 10.09.25 | Exousia Pro, Inc.: Exousia Pro Files Provisional Patent for Novel Extracellular Vesicle Loading Method, Tapping into Multi-Billion Dollar Markets | 417 | ACCESS Newswire | ORLANDO, FL / ACCESS Newswire / September 10, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company and innovator in exosome-based therapies, today announced a key strategic... ► Artikel lesen |
1 2 Weiter >>
22 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SARTORIUS AG VZ | 243,40 | -1,46 % | Sartorius: Satter Kurssprung - Kursziel rauf | Die Aktie des Laborausrüsters Sartorius hat am Donnerstag kräftig zugelegt. Auf der Handelsplattform Xetra gingen die Vorzüge der Gesellschaft mit einem Plus von 6,9 Prozent aus dem Handel. Der MDAX-Wert... ► Artikel lesen | |
| PVA TEPLA | 36,640 | -4,78 % | PVA TEPLA AG - Stabilität als strategischer Raum | ||
| EVOLV TECHNOLOGIES | 5,660 | -2,08 % | NSE - Evolv Technologies Holdings, Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
| LIGHTWAVE LOGIC | 6,230 | 0,00 % | Aktien New York Ausblick: Rekordrally pausiert - Halbleiter-Hausse geht weiter | NEW YORK (dpa-AFX) - Die US-Börsen dürften nach der jüngsten Rekordjagd am Dienstag erst einmal eine Pause einlegen. Dank der anhaltenden Halbleiter-Hausse sowie optimistischer Aussagen von US-Präsident... ► Artikel lesen | |
| DRONESHIELD | 1,300 | -7,18 % | DroneShield-Aktie: 121 % Umsatzplus - läuft die Rally weiter? | DroneShield hat das erste Quartal 2026 mit einem Umsatz von 74,1 Mio. US$ abgeschlossen. Das sind 121 Prozent mehr als im Vorjahreszeitraum. Ein Großauftrag des US-Verteidigungsministeriums über knapp... ► Artikel lesen | |
| GPGI | 14,510 | -2,72 % | GPGI, Inc.: Husky Technologies Appoints Mohammad Kanaan as Chief Financial Officer and Karen Stone as Chief Human Resources Officer | BOLTON, Ontario, May 28, 2026 (GLOBE NEWSWIRE) -- GPGI, Inc. (NYSE: GPGI) today announced the appointments of Mohammad Kanaan as Chief Financial Officer and Karen Stone as Chief Human Resources Officer... ► Artikel lesen | |
| 2G ENERGY | 63,00 | -1,25 % | 2G Energy: Konsolidierung als Kaufchance | Nach der höchst dynamischen Kursentwicklung seit dem Tief im März hat die Aktie von 2G Energy zuletzt einen Teil ihrer Gewinne wieder abgegeben. Genau diese Schwächephase hat Vorstandschef Pablo Hofelich... ► Artikel lesen | |
| SERVE ROBOTICS | 5,095 | -3,32 % | Serve Robotics: A Risky Bet or a Future Winner? | ||
| ITURAN LOCATION AND CONTROL | 55,74 | 0,00 % | Dividendenbekanntmachungen (24.06.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AH REALTY TRUST INC US04208T1088 0,14 USD 0,1229 EUR AMBEV SA ADR US02319V1035 0,0091 USD 0,008 EUR ARLANDASTAD GROUP AB SE0016276851 1... ► Artikel lesen | |
| UNUSUAL MACHINES | 16,935 | +1,71 % | Unusual Machines, Inc.: Unusual Machines Promotes Tyler Crane to Vice President of Product | Promotion reflects the Company's continued investment in product leadership ORLANDO, FL / ACCESS Newswire / July 13, 2026 / Unusual Machines, Inc. (NYSE American:UMAC), a leading manufacturer of NDAA-compliant... ► Artikel lesen | |
| AIRJOULE TECHNOLOGIES | 3,755 | 0,00 % | AirJoule Technologies Corporation: AirJoule Technologies Announces First Quarter 2026 Results and Provides Business Update | RONAN, Mont., May 14, 2026 (GLOBE NEWSWIRE) -- AirJoule Technologies Corporation (NASDAQ: AIRJ) ("AirJoule Technologies" or "AIRJ"), a leading platform technology that unleashes the power of water... ► Artikel lesen | |
| AXON ENTERPRISE | 443,80 | -6,31 % | $1000 Invested In Axon Enterprise 5 Years Ago Would Be Worth This Much Today | ||
| KRATOS DEFENSE | 40,530 | -1,31 % | Rüstungsaktien: Warum das Daten-Nadelöhr für Kratos, Cathie Wood und Harvest Technology zum Schlüsselfaktor wird | ||
| VUSION | 116,40 | +2,74 % | Decathlon Reaches 700 Stores Equipped with Vusion Solutions | The Vusion platform, now deployed across 54 countries on three continents, enhances operational efficiency for Decathlon teams and improves customer experience.PARIS, July 15, 2026 /PRNewswire/... ► Artikel lesen | |
| PFEIFFER VACUUM TECHNOLOGY | 165,00 | -0,48 % | Dividendenbekanntmachungen (13.07.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AS COMPANY SA GRS404003006 - 0,1919 EUR BANK OZK US06417N1037 0,48 USD 0,4204 EUR BEACON MINERALS LIMITED AU000000BCN0 0,1 AUD 0... ► Artikel lesen |
EXOUSIA ADVANCED MATERIALS INC gehört der Branche Sonstige Technologie an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu EXOUSIA ADVANCED MATERIALS INC finden Sie auf Wallstreet Online.